 
    Sofía Pérez-Del-Pulgar
Research group
- Viral, genetic and immune-mediated liver diseases Accredited researcher (R3A)
Featured publications
- 
                    Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architectureAuthors:Reference: Nature Communications 2021.
- 
                    Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearanceAuthors:Reference: Elife 2021.
- 
                    Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patientsAuthors:Reference: Journal Of Hepatology 2021.
- 
                    Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantationAuthors:Reference: Journal Of General Virology 2019.
- 
                    Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals.Authors:Reference: Journal Of Viral Hepatitis 2018.
- 
                    Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by ultra-deep pyrosequencingAuthors:Reference: Journal Of Clinical Virology 2017.
- 
                    Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell cultureAuthors:Reference: Nature Microbiology 2017.
- 
                    Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free RegimenAuthors:Reference: Gastroenterology 2016.
- 
                    Clinical relevance of the study of hepatitis B virus covalently closed circular DNAAuthors:Reference: Liver International 2016.
- 
                    Hepatitis C virus infection inhibits P-body granule formation in human liversAuthors:Reference: Journal Of Hepatology 2015.
Featured Projects
- 
                Study of cccDNA persistence during HBV infection in vivo, and in vitro using a bioreactor that mimics the liver microenvironmentPrincipal investigator: Sofia Perez del Pulgar GallartFunder: Instituto de Salud Carlos IIICode: PI16/00111Duration: 01/01/2017 - 31/12/2019
- 
                Virological and immunological factors associated with hepatitis C and hepatitis B virus infection recurrence after treatment discontinuationPrincipal investigator: Xavier Forns BernhardtFunder: Gilead EspañaDuration: 07/03/2016 - 06/03/2018
- 
                TherVacB: A therapeutic vaccine to cure hepatitis BPrincipal investigator: Xavier Forns BernhardtFunder: European CommissionCode: 848223Duration: 01/01/2020 - 31/12/2024
- 
                Interplay between HBV, HDV and host factors: impact on liver disease progression (InBDeL)Principal investigator: Sofia Perez del Pulgar GallartFunder: ISCIIICode: PI19/00036Duration: 01/01/2020 - 31/12/2022
- 
                Viral and immune factors associated with antiviral treatment and hepatitis C recurrence after liver transplantationPrincipal investigator: Sofia Perez del Pulgar GallartFunder: Instituto de Salud Carlos IIICode: PI13/00155Duration: 01/01/2014 - 30/03/2017
